ANI Pharmaceuticals Inc

NASDAQ:ANIP  
38.62
+0.90 (+2.39%)
Other Pre-Announcement

ANI Pharmaceuticals Reports Q4 Adjusted Earnings Per Share $0.80

Published: 03/09/2021 12:03 GMT
ANI Pharmaceuticals Inc (ANIP) - Ani Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth.
Q4 Adjusted Non-GAAP Earnings per Share $0.80.
Q4 GAAP Loss per Share $0.30.
Q4 Revenue $57.3 Million Versus Refinitiv Ibes Estimate of $54.3 Million.
Q4 Earnings per Share Estimate $0.94 -- Refinitiv Ibes Data (analyst estimates).